
Early-stage B2B venture capital firm backed by experienced enterprise operators who invest alongside it

A venture fund backing early-stage food and feed companies working on alternative protein and sustainability

VisVires New Protein is a venture capital firm that describes itself as an early mover in putting capital into new protein. It backs teams building healthier, safer and more sustainable food and animal feed systems.
The fund looks for companies with strong intellectual property, rigorous science and management teams focused on delivery. It also wants solutions that can be applied worldwide, especially in Asia. It targets problems such as unsustainable production, disease in livestock and aquaculture, antibiotic resistance and diet-related illness.
Summary written by TrustList from the business's own published information, Sep 2026.
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about VisVires New Protein.
Similar listings buyers compare against this one.

Early-stage B2B venture capital firm backed by experienced enterprise operators who invest alongside it

Member-based investor group funding early-stage companies through monthly review and a chapter roadshow

Silicon Valley venture capital firm investing from seed to growth stage across technology sectors

Global venture capital firm and accelerator backing early-stage technology founders, formerly called 500 Startups

An investment and advisory firm for the life science industry, run by experienced operating executives

A consumer-focused venture fund investing in products, commerce platforms and emerging web3 applications

Growth equity firm investing in information and software businesses
Everything here links back to the same verified catalogue. Pick your next stop.